Rip and a team in Rockville help fast track our response to pandemics
What role does our Rockville site play?
In the wake of the Ebola and Zika outbreaks, there is consensus that the world needs to be better prepared for pandemics. Under the leadership of Rip Ballou, a team at our Rockville site (The Slaoui Center for Vaccines Research) will play a critical role in helping to ensure this happens.
Rip, who is by trade a medical doctor, began his work in vaccines at the Walter Reed Army Institute of Research. While there, he led the team, with GSK, to co-develop a malaria vaccine. Now, based in Rockville, Rip is once again leading. This time – he’s leading a team to fast track our response to pandemics.
A critical element of this effort will come from our support for the Coalition for Epidemic Preparedness Innovations (CEPI), which brings together governments, funders, and pharmaceutical companies under the banner of outsmarting epidemics. CEPI is galvanizing efforts to get new vaccines developed, approved, and manufactured against potential threats before they happen.
With Rip and his team in Rockville, we’re in position to make an important contribution to improving global health preparedness.